Titlebook: Cancer Immunotherapy; Paradigms, Practice Tyler J. Curiel Book 2013 Springer Science+Business Media New York 2013 Anti-tumor immunity.Canc

papertrans

書目名稱Cancer Immunotherapy影響因子(影響力)




書目名稱Cancer Immunotherapy影響因子(影響力)學科排名




書目名稱Cancer Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Cancer Immunotherapy網(wǎng)絡(luò)公開度學科排名




書目名稱Cancer Immunotherapy被引頻次




書目名稱Cancer Immunotherapy被引頻次學科排名




書目名稱Cancer Immunotherapy年度引用




書目名稱Cancer Immunotherapy年度引用學科排名




書目名稱Cancer Immunotherapy讀者反饋




書目名稱Cancer Immunotherapy讀者反饋學科排名

Blanch

T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment. In this chapter, we review and summarize current knowledge regarding the function, interactions, and prognostic significance of each of these populations, as well as their dependence upon one another within the tumor microenvironment.

dominant

NEEDY

Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Conceptsthe lymphoid organs where they present the antigen and control the activation of B and T cells, the mediators of specific immunity. DC-based immunotherapy is explored worldwide in clinical vaccination trials with cancer patients aiming to induce or augment an antitumor immune response. The majority

打火石

Peptide and Protein-Based Cancer Vaccinesons and early mobilization of the immune system. In cancer, tumor cells have evolved to overcome immune surveillance or grow in the presence of exhausted immune cells. However, the identification of tumor-infiltrating lymphocytes as good prognostic indicator of increased survival in cancer disease 1

圓柱

Antigen Targeting to Dendritic Cells for Cancer Immunotherapyigrate to the draining lymph nodes where they can induce an antigen-specific T cell response. A promising strategy to induce a potent, specific, and lasting anti-tumor response is to target tumor antigens to DC in vivo. This represents a clinically generally applicable and cost-effective approach to

圓柱

Cytokines in the Treatment of Cancertokines classified by their receptor usage. The effects of individual cytokines on immunity depend on several factors, including the local cytokine concentration, the pattern of cytokine receptor expression, and the integration of multiple signaling pathways in responding immune cells. Cytokines hav

fringe

CRUE

Managing Regulatory T Cells to Improve Cancer Immunotherapynt cancer histologies. Cancer Tregs not only are capable of impeding endogenous protective anti-tumor immunity from optimal functioning but are also capable of impeding the efficacy of anti-cancer immunotherapy. Tumor-associated Tregs represent heterogeneous populations, differing by their origins a

Override